Evaluation of the effect of Bovis Calculus Artifactus on eight rat liver cytochrome P450 isozymes using LC-MS/MS and cocktail approach

References

• Achour B, Russell MR, Barber J, Rostami-Hodjegan A. 2014. Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5′-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics. Drug Metab Dispos. 42(4):500–510.
   PubMed Web of Science ®Google Scholar
• Akakpo J, Ramachandran A, Kandel S, Ni H, Kumer S, Rumack B, Jaeschke H. 2018. 4-Methylpyrazole protects against acetaminophen hepatotoxicity in mice and in primary human hepatocytes. Hum Exp Toxicol. 37(12):1310–1322.
   PubMed Web of Science ®Google Scholar
• Al-Ramahi R, Jaradat N, Shalalfeh R, Nasir S, Manasra Y, Shalalfeh I, Esam Y. 2015. Evaluation of potential drug-herb interactions among a group of Palestinian patients with chronic diseases. BMC Complement Altern Med. 15(1):221.
   PubMedGoogle Scholar
• Asha S, Vidyavathi M. 2010. Role of human liver microsomes in in vitro metabolism of drugs-a review. Appl Biochem Biotechnol. 160(6):1699–1722.
   PubMed Web of Science ®Google Scholar
• Astin JA, Marie A, Pelletier KR, Hansen E, Haskell WL. 1998. A review of the incorporation of complementary and alternative medicine by mainstream physicians. Arch Intern Med. 158(21):2303–2310.
   PubMed Web of Science ®Google Scholar
• Besnik B, Sadagopan K, James FR. 2008. Microsome biocolloids for rapid drug metabolism and in hibition assessment by LC-MS. Drug Metab Lett. 2:158–162.
   PubMedGoogle Scholar
• Bogaards JJ, Bertrand M, Jackson P, Oudshoorn MJ, Weaver RJ, van Bladeren PJ, Walther B. 2000. Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica. 30(12):1131–1152.
   PubMed Web of Science ®Google Scholar
• Bourgogne E, Saucez G, Dell’aiera S, Rosa M, Jacques-Hespel C, Gerin B, Chanteux H, Nicolas JM. 2011. An in-vitro validation study in the field of toxicokinetics and metabolism: Validation of an LC–MS/MS assay for simultaneous assessment of cytochrome P450 activity using cryopreserved human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, CYP2C9 and CYP1A2. Toxicol Lett. 205:S60–S179.
   Web of Science ®Google Scholar
• Chinese Pharmacopoeia Commission. 2020. Chinese pharmacopoeia. Vol I. Beijing: China Medical Science and Technology Press; p. 5–8.
   Google Scholar
• De Smet PAGM. 2002. Herbal remedies. N Engl J Med. 347(25):2046–2056.
   PubMed Web of Science ®Google Scholar
• De Wildt SN, Kearns GL, Leeder JS, Van Den Anker JN. 1999. Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet. 37(6):485–505.
   PubMed Web of Science ®Google Scholar
• Di YM, Chow VD-W, Chow Yang L-P, Zhou S-F. 2009. Structure, function, regulation and polymorphism of human cytochrome P450 2A6. Curr Drug Metab. 10(7):754–780.
   PubMed Web of Science ®Google Scholar
• Dierks EA, Stams KR, Lim H-K, Cornelius G, Zhang H, Ball SE. 2001. A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450S using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectetrometry. Drug Metab Dispos. 29:23–29.
   PubMed Web of Science ®Google Scholar
• Eagling VA, Tjia JF, Back DJ. 1998. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. Br J Clin Pharmacol. 45(2):107–114.
   PubMed Web of Science ®Google Scholar
• Ernst E. 2002. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John’s Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med. 136(1):42–53.
   PubMed Web of Science ®Google Scholar
• Geng T, Si H, Kang D, Li Y, Huang W, Ding G, Wang Z, Bi Y, Zhang H, Xiao W. 2015. Influences of Re Du ning injection, a traditional Chinese medicine injection, on the CYP450 activities in rats using a cocktail method. J Ethnopharmacol. 174:426–436.
   PubMed Web of Science ®Google Scholar
• Giancarlo GM, Venkatakrishnan K, Granda BW, Von Moltke LL, Greenblatt DJ. 2001. Relative contributions of CYP2C9 and 2C19 to phenytoin 4-hydroxylation in vitro: inhibition by sulfaphenazole, omeprazole, and ticlopidine. Eur J Clin Pharmacol. 57(1):31–36.
   PubMed Web of Science ®Google Scholar
• Hammerness P, Basch E, Ulbricht C, Barrette EP, Foppa I, Basch S, Bent S, Boon H, Ernst E, 2003. St John’s wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist. Psychosomatics. 44(4):271–282.
   PubMed Web of Science ®Google Scholar
• Han YL, Li D, Ren B, Jing GP, Meng XL, Zhou ZY, Yu Q, Li Y, Wan LL, Guo C. 2012. Evaluation of impact of Herba Erigerontis injection, a Chinese herbal prescription, on rat hepatic cytochrome P450 enzymes by cocktail probe drugs. J Ethnopharmacol. 139(1):104–109.
   PubMed Web of Science ®Google Scholar
• Izzo AA, Ernst E. 2001. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs. 61(15):2163–2175.
   PubMed Web of Science ®Google Scholar
• Jiang B, Shi M, Chen J, Yang J, Zhang K, Guo C, Han Y. 2021. In vitro inhibition by 79 herb injectables of nine human cytochrome P450 isoenzymes: a systematic evaluation of herb-drug interactions. Acta Pharm Sin. 56(1):274–282.
   Google Scholar
• Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. 2002. Recent patterns of medication use in the ambulatory adult population of the United States: the slone survey. JAMA. 287(3):337–344.
   PubMed Web of Science ®Google Scholar
• Kawakami H, Ohtsuki S, Kamiie J, Suzuki T, Abe T, Terasaki T. 2011. Simultaneous absolute quantification of 11 cytochrome P450 isoforms in human liver microsomes by liquid chromatography tandem mass spectrometry with in silico target peptide selection. J Pharm Sci. 100(1):341–352.
   PubMed Web of Science ®Google Scholar
• Kelly JP, Kaufman DW, Kelley K, Rosenberg L, Anderson TE, Mitchell AA. 2005. Recent trends in use of herbal and other natural products. Arch Intern Med. 165(3):281–286.
   PubMed Web of Science ®Google Scholar
• Kim MJ, Kim H, Cha IJ, Park JS, Shon JH, Liu KH, Shin JG. 2005. High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 19(18):2651–2658.
   PubMed Web of Science ®Google Scholar
• Kozakai K, Yamada Y, Oshikata M, Kawase T, Suzuki E, Haramaki Y, Taniguchi H. 2012. Reliable high-throughput method for inhibition assay of 8 cytochrome P450 isoforms using cocktail of probe substrates and stable isotope-labeled internal standards. Drug Metab Pharmacokinet. 27(5):520–529.
   PubMed Web of Science ®Google Scholar
• Lee JT, Pao LH, Hsiong CH, Huang PW, Shih TY, Yoa-Pu Hu O. 2013. Validated liquid chromatography-tandem mass spectrometry method for determination of totally nine probe metabolites of cytochrome P450 enzymes and UDP-glucuronosyltransferases. Talanta. 106:220–228.
   PubMed Web of Science ®Google Scholar
• Lee KS, Kim SK. 2013. Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions. J Appl Toxicol. 33(2):100–108.
   PubMed Web of Science ®Google Scholar
• Li G, Huang K, Nikolic D, Van Breemen RB. 2015. High-throughput cytochrome P450 cocktail inhibition assay for assessing drug-drug and drug-botanical interactions. Drug Metab Dispos. 43(11):1670–1678.
   PubMed Web of Science ®Google Scholar
• Li G, Simmler C, Chen L, Nikolic D, Chen S-N, Pauli GF, Van Breemen RB. 2017. Cytochrome P450 inhibition by three licorice species and fourteen licorice constituents. Eur J Pharm Sci. 109:182–190.
   PubMed Web of Science ®Google Scholar
• Lin W, Zhang J, Ling X, Yu N, Li J, Yang H, Li R, Cui J. 2013. Evaluation of the effect of TM208 on the activity of five cytochrome P450 enzymes using on-line solid-phase extraction HPLC-DAD: a cocktail approach. J Chromatogr B Analyt Technol Biomed Life Sci. 923-924:29–36.
   PubMed Web of Science ®Google Scholar
• Lin Y, Wei Y, Hu X, Wu M, Ying X, Ding M. 2018. Influences of Oldenlandia diffusa on the CYP450 activities in rats using a cocktail method by UHPLC-MS/MS. Biochem Res Int. 2018:1467143.
   PubMed Web of Science ®Google Scholar
• Liu LY, Han YL, Zhu JH, Yu Q, Yang QJ, Lu J, Guo C. 2015. A sensitive and high-throughput LC-MS/MS method for inhibition assay of seven major cytochrome P450s in human liver microsomes using an in vitro cocktail of probe substrates. Biomed Chromatogr. 29(3):437–444.
   PubMed Web of Science ®Google Scholar
• Martignoni M, Groothuis GM, de Kanter R. 2006. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol. 2(6):875–894.
   PubMed Web of Science ®Google Scholar
• Michielan L, Terfloth L, Gasteiger J, Moro S. 2009. Comparison of multilabel and single-label classification applied to the prediction of the isoform specificity of cytochrome P450 substrates. J Chem Inf Model. 49(11):2588–2605.
   PubMed Web of Science ®Google Scholar
• Miller GP. 2008. Advances in the interpretation and prediction of CYP2E1 metabolism from a biochemical perspective. Expert Opin Drug Metab Toxicol. 4(8):1053–1064.
   PubMed Web of Science ®Google Scholar
• Miners JO, Birkett DJ. 1998. Cytochrome P4502C9: an enzyme of major importance in human drug metabolism. Br J Clin Pharmacol. 45(6):525–538.
   PubMed Web of Science ®Google Scholar
• Otten JN, Hingorani GP, Hartley DP, Kragerud SD, Franklin RB. 2011. An in vitro, high throughput, seven cyp cocktail inhibition assay for the evaluation of new chemical entities using LC-MS/MS. Drug Metab Lett. 5:17–24.
   PubMedGoogle Scholar
• Pelkonen O, Rautio A, Raunio H, Pasanen M. 2000. CYP2A6: a human coumarin 7-hydroxylase. Toxicology. 144(1–3):139–147.
   PubMed Web of Science ®Google Scholar
• Peng C, Tian J, Lv M, Huang Y, Tian Y, Zhang Z. 2014. Development and validation of a sensitive LC-MS-MS method for the simultaneous determination of multicomponent contents in artificial Calculus Bovis. J Chromatogr Sci. 52(2):128–136.
   PubMed Web of Science ®Google Scholar
• Qiao X, Ji S, Yu SW, Lin XH, Jin HW, Duan YK, Zhang LR, Guo DA, Ye M. 2014. Identification of key licorice constituents which interact with cytochrome P450: evaluation by LC/MS/MS cocktail assay and metabolic profiling. AAPS J. 16(1):101–113.
   PubMed Web of Science ®Google Scholar
• Qin CZ, Ren X, Tan ZR, Chen Y, Yin JY, Yu J, Qu J, Zhou HH, Liu ZQ. 2014. A high-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography-tandem mass spectrometry. Biomed Chromatogr. 28(2):197–203.
   PubMed Web of Science ®Google Scholar
• Rendic S, Carlo FJD. 1997. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab Rev. 29(1–2):413–580.
   PubMed Web of Science ®Google Scholar
• Rendic S, Guengerich FP. 2012. Summary of information on the effects of ionizing and non-ionizing radiation on cytochrome P450 and other drug metabolizing enzymes and transporters. Curr Drug Metab. 13(6):448–787.
   Web of Science ®Google Scholar
• Shader RI, Granda BW, Von Moltke LL, Giancarlo GM, Greenblatt DJ. 1999. Inhibition of human cytochrome P450 isoforms in vitro by zafirlukast. Biopharm Drug Dispos. 20(8):385–388.
   PubMed Web of Science ®Google Scholar
• Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. 1994. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther. 270:414–423.
   PubMed Web of Science ®Google Scholar
• Shimamoto J, Ieiri I, Urae A, Kimura M, Irie S, Kubota T, Chiba K, Ishizaki T, Otsubo K, Higuchi S. 2000. Lack of differences in diclofenac (a substrate for CYP2C9) pharmacokinetics in healthy volunteers with respect to the single CYP2C9*3 allele. Eur J Clin Pharmacol. 56(1):65–68.
   PubMed Web of Science ®Google Scholar
• Sun W, Wang Z, Chen R, Huang C, Sun R, Hu X, Li W, Chen R. 2017. Influences of anlotinib on cytochrome P450 enzymes in rats using a cocktail method. Biomed Res Int. 2017:3619723.
   PubMed Web of Science ®Google Scholar
• Testino SA, Patonay G. 2003. High-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography–tandem mass spectrometry. J Pharm Biomed Anal. 30(5):1459–1467.
   PubMed Web of Science ®Google Scholar
• Turpeinen M, Uusitalo J, Jouko U, Jalonen J, Jorma J, Pelkonen O, Olavi P. 2005. Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay. Eur J Pharm Sci. 24(1):123–132.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research & Center for Veterinary Medicine. 2018. Bioanalytical method validation guidance for industry. Silver Spring, MD: Center for Drug Evaluation and Research, Center for Veterinary Medicine; p. 1–41.
   Google Scholar
• U.S. Department of Health and Human Services, Food and Drug Administration & Center for Drug Evaluation and Research (CDER). 2020. In vitro drug interaction studies — cytochrome P450 enzyme and transporter-mediated drug interactions guidance for industry. Silver Spring, MD: Center for Drug Evaluation and Research; p. 1–43.
   Google Scholar
• Venhorst J, ter Laak AM, Commandeur JN, Funae Y, Hiroi TV, Ermeulen NP. 2003. Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities. J Med Chem. 46(1):74–86.
   PubMed Web of Science ®Google Scholar
• Videau O, Pitarque S, Troncale S, Hery P, Thevenot E, Delaforge M, Benech H. 2012. Can a cocktail designed for phenotyping pharmacokinetics and metabolism enzymes in human be used efficiently in rat? Xenobiotica. 42(4):349–354.
   PubMed Web of Science ®Google Scholar
• Walker FA. 2005. Nitric oxide interaction with insect nitrophorins and thoughts on the electron configuration of the {FeNO}6 complex. J Inorg Biochem. 99(1):216–236.
   PubMed Web of Science ®Google Scholar
• Walsky RL, Obach RS. 2004. Validated assays for human cytochrome P450 activities. Drug Metab Dispos. 32(6):647–660.
   PubMed Web of Science ®Google Scholar
• Wang JJ, Guo JJ, Zhan J, Bu HZ, Lin JH. 2014. An in-vitro cocktail assay for assessing compound-mediated inhibition of six major cytochrome P450 enzymes. J Pharm Anal. 4(4):270–278.
   PubMedGoogle Scholar
• Wang S, Li W, Yang J, Yang Yang Z, Yang C, &, J. Hongtao 2020. Research progress of herbal medicines on drug metabolizing enzymes: consideration based on toxicology. Curr Drug Metab. 21(12):913–927.
   PubMed Web of Science ®Google Scholar
• Wienkers LC, Heath TG. 2005. Predicting in vivo drug interactions from in vitro drug discovery data. Nat Rev Drug Discov. 4(10):825–833.
   PubMed Web of Science ®Google Scholar
• Xia L, Chen W, Liu J, Wang B, Wang S, Zhou Y. 2021. Establishment and application of detection methods for cytochrome P450 enzyme activities in vivo and in vitro of rats. Chin Mod Dr. 59:32–37.
   Google Scholar
• Yang X, Ye J, Sun G, Xue B, Zhao Y, Miao P, Su J, Zhang Y. 2014. Identification of metabolites of epiberberine in rat liver microsomes and its inhibiting effects on CYP2D6. Chin J of Chin Mater Med. 39:3855–3859.
   Google Scholar
• Yao M, Cai H, Zhu M. 2012. Fast and reliable CYP inhibition assays. In: Zhang D. & Surapaneni S., editors. ADME-enabling technologies in drug design and development. Hoboken: John Wiley & Sons, Inc.; p. 213–232.
   Google Scholar
• Yin H, Racha J, Li SY, Olejnik N, Satoh H, Moore D. 2000. Automated high throughput human CYP isoform activity assay using SPE-LC/MS method: application in CYP inhibition evaluation. Xenobiotica. 30(2):141–154.
   PubMed Web of Science ®Google Scholar
• Zanger UM, Klein K, Saussele T, Blievernicht JH, Hofmann M, Schwab M. 2007. Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance. Pharmacogenomics. 8(7):743–759.
   PubMed Web of Science ®Google Scholar
• Zhang QH, Hu JP, Wang BL, Li Y. 2012. Effects of capsaicin and dihydrocapsaicin on human and rat liver microsomal CYP450 enzyme activities in vitro and in vivo. J Asian Nat Prod Res. 14(4):382–395.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang S, Ding T, Chen M, Wang L, Wu M, Hu G, Lu X. 2014. Evaluation of the effect of apatinib (YN968D1) on cytochrome P450 enzymes with cocktail probe drugs in rats by UPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 973C:68–75.
   PubMed Web of Science ®Google Scholar
• Zientek M, Miller H, Smith D, Dunklee MB, Heinle L, Thurston A, Lee C, Hyland R, Fahmi O, Burdette D. 2008. Development of an in vitro drug-drug interaction assay to simultaneously monitor five cytochrome P450 isoforms and performance assessment using drug library compounds. J Pharmacol Toxicol Methods. 58(3):206–214.
   PubMedGoogle Scholar